ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNG Synairgen Plc

4.675
0.00 (0.00%)
Last Updated: 08:00:27
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.675 4.36 4.99 - 38,838 08:00:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.41M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.68p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.41 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 1951 to 1971 of 99175 messages
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
01/4/2020
16:58
Thanks Makendon, interesting comment from
the spin off CEO:

“We need a ‘Big Pharma’ partner to help us scale up our activities,” he said.

I think PIs who are selling thinking we are at the end of the news flow cycle for a while will be in for a shock. I suspect it I just about to start

talk2dubya
01/4/2020
16:40
I think the following is worth watching and in depth analysis of Covid-19. It’s about 40 mins long but lots of detail:
makendon
01/4/2020
16:35
As Covid-19 started to gather steam in China, Synairgen tried to get things started, but to no avail. Italy was the next plan. “We had some really good interaction there,” said Marsden. “But they went from, you know, just busy to very busy to extremely busy to unable-to-communicate busy.”

Eventually, they decided their home ground — the UK, where they have an ongoing COPD trial — would be the best place to kick off a Covid-19 study. Initially, the pilot phase of the trial will have 100 patients (50 will get a placebo, and 50 will get SNG001). If all goes well, a pivotal study will be conducted.

makendon
01/4/2020
16:34
I dont think it is the WHO trial toff but it is interferon.
tidy 2
01/4/2020
16:25
I think you will find that FARN is in the WHO trial
toffeeman
01/4/2020
16:15
just thinking - perhaps the reason he avoided the WHO question is because they may currently be in discussions about its inclusion....
hms_trader
01/4/2020
15:18
and i would assume "later in the year" means quite soon as there is an immediate urgency to save as many lives as possible around the world.
asif12
01/4/2020
15:03
I guess this bit from the CEO, Richard Marsden:

" Now we are talking about to scale up to hundreds of thousands and millions of doses later this year."

Would correlate with the £ Billions opportunity for SNG described by Finncap and their comparisons to £3 Billion Avigan and $11 Billion Gilead.

:o)

jev1
01/4/2020
14:59
Although you expect them to plan ahead for production it is always nice to hear it confirmed. Thanks for posting the interview and the youtube link.
pdt
01/4/2020
14:53
Finncap driving this upwards as they are aggressively on the bid and bidding up for stock. Hmmm interesting....
nobbygnome
01/4/2020
14:44
Sounds like a banker Jev
tidy 2
01/4/2020
14:43
Yes the last part about already having the partner / infrastructure in place to scale up production to millions of doses later this year is brilliant.
74tom
01/4/2020
14:41
Love this part at the end:

_____



" Now we are talking about to scale up to hundreds of thousands and millions of doses later this year."

jev1
01/4/2020
14:32
Great BBC at last!!
hazl
01/4/2020
14:23
WHY NO TICK UPS for Likya123 on the other thread ???

Shamefull:((

Didn't see yours Nobby:(

bmnsa
01/4/2020
13:53
Never write anyone off too soon (likya123)
bmnsa
01/4/2020
13:52
Yes must admit there was no need to avoid the WHO question. Shame as it may detract from what otherwise was a good interview.
rafboy
01/4/2020
13:51
Wow great interview MS side looks successful too there will be a massive world wide demand for interferon 1b now & in the future
bobaxe1
01/4/2020
13:39
Tidy2 I liked the article other than he repeat himself and evaded the question when he was asked about WHO. Otherwise ok (to someone not in the medical profession).
makendon
01/4/2020
13:36
Good interview
tidy 2
01/4/2020
13:31
Nobby, great find, I have posted a YouTube link below to the specific section from the report
makendon
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older

Your Recent History

Delayed Upgrade Clock